Kurt J. Hilzinger - Dec 31, 2022 Form 4 Insider Report for HUMANA INC (HUM)

Role
Director
Signature
Kurt J. Hilzinger
Stock symbol
HUM
Transactions as of
Dec 31, 2022
Transactions value $
$199,015
Form type
4
Date filed
1/4/2023, 01:17 PM
Previous filing
Oct 7, 2022
Next filing
Mar 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HUM Humana Common 19.4K Dec 31, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Restricted Stock Units Award $105K +205 +12.21% $510.30 1.88K Dec 31, 2022 Humana Common 205 Direct F2
transaction HUM Restricted Stock Units Award $94.4K +185 +1.56% $510.30 12K Dec 31, 2022 Humana Common 185 Direct F3
transaction HUM Restricted Stock Units Award $0 +380 $0.00 380 Jan 3, 2023 Humana Common 380 Direct F4
holding HUM Restricted Stock Units 22.4K Dec 31, 2022 Humana Common 22.4K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F2 Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
F3 Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F4 Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023.